Cancer
FAP alpha 639-647 (HLA-A*02:01) GLFKCGIAV
Product number: EP11169_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
#
TechData
| Sequence: | GLFKCGIAV |
| Gene: | FAP |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Prolyl endopeptidase FAP |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |
Skip product gallery
More FAP peptides
FAP 735-744 (HLA-A*02:01)
From
€105.00*
GLSGLSTNHL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from fibroblast activation protein (FAP) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.